These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 17332341)
1. GATA-1 is essential in EGF-mediated induction of nucleotide excision repair activity and ERCC1 expression through ERK2 in human hepatoma cells. Andrieux LO; Fautrel A; Bessard A; Guillouzo A; Baffet G; Langouët S Cancer Res; 2007 Mar; 67(5):2114-23. PubMed ID: 17332341 [TBL] [Abstract][Full Text] [Related]
2. MAPK dependence of DNA damage repair: ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in a MEK1/2 dependent fashion. Yacoub A; Park JS; Qiao L; Dent P; Hagan MP Int J Radiat Biol; 2001 Oct; 77(10):1067-78. PubMed ID: 11682011 [TBL] [Abstract][Full Text] [Related]
3. Nucleotide excision repair is not required for the antiapoptotic function of insulin-like growth factor 1. Lee-Kwon W; Park D; Bernier M Exp Cell Res; 1998 Jun; 241(2):458-66. PubMed ID: 9637787 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of the two nucleotide excision repair genes ERCC1 and XPC in human hepatocellular carcinoma. Fautrel A; Andrieux L; Musso O; Boudjema K; Guillouzo A; Langouët S J Hepatol; 2005 Aug; 43(2):288-93. PubMed ID: 15922480 [TBL] [Abstract][Full Text] [Related]
5. Activation of extracellular signal-regulated kinase signaling by epidermal growth factor mediates c-Jun activation and p300 recruitment in keratin 16 gene expression. Wang YN; Chen YJ; Chang WC Mol Pharmacol; 2006 Jan; 69(1):85-98. PubMed ID: 16214953 [TBL] [Abstract][Full Text] [Related]
6. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells. Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520 [TBL] [Abstract][Full Text] [Related]
7. [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma]. Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Mao CP Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):917-20. PubMed ID: 17953842 [TBL] [Abstract][Full Text] [Related]
8. Adenosine A2A receptor occupancy stimulates collagen expression by hepatic stellate cells via pathways involving protein kinase A, Src, and extracellular signal-regulated kinases 1/2 signaling cascade or p38 mitogen-activated protein kinase signaling pathway. Che J; Chan ES; Cronstein BN Mol Pharmacol; 2007 Dec; 72(6):1626-36. PubMed ID: 17872970 [TBL] [Abstract][Full Text] [Related]
9. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4. Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433 [TBL] [Abstract][Full Text] [Related]
10. PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro. Toulany M; Dittmann K; Fehrenbacher B; Schaller M; Baumann M; Rodemann HP DNA Repair (Amst); 2008 Oct; 7(10):1746-56. PubMed ID: 18678286 [TBL] [Abstract][Full Text] [Related]
11. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells. Ushio K; Hashimoto T; Kitamura N; Tanaka T Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783 [TBL] [Abstract][Full Text] [Related]
12. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells. Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors. Zhao LJ; Wang L; Ren H; Cao J; Li L; Ke JS; Qi ZT Exp Cell Res; 2005 Apr; 305(1):23-32. PubMed ID: 15777784 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor-induced cyclooxygenase-2 expression in oral squamous cell carcinoma cell lines is mediated through extracellular signal-regulated kinase 1/2 and p38 but is Src and nuclear factor-kappa B independent. Husvik C; Bryne M; Halstensen TS Eur J Oral Sci; 2009 Oct; 117(5):528-35. PubMed ID: 19758248 [TBL] [Abstract][Full Text] [Related]
15. Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells. Chen YL; Lin PC; Chen SP; Lin CC; Tsai NM; Cheng YL; Chang WL; Lin SZ; Harn HJ J Pharmacol Exp Ther; 2007 Nov; 323(2):746-56. PubMed ID: 17715378 [TBL] [Abstract][Full Text] [Related]
16. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells. Bessard A; Frémin C; Ezan F; Coutant A; Baffet G J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199 [TBL] [Abstract][Full Text] [Related]
17. Growth-related signaling regulates activation of telomerase in regenerating hepatocytes. Inui T; Shinomiya N; Fukasawa M; Kobayashi M; Kuranaga N; Ohkura S; Seki S Exp Cell Res; 2002 Feb; 273(2):147-56. PubMed ID: 11822870 [TBL] [Abstract][Full Text] [Related]
18. Oncogenic H-Ras up-regulates expression of ERCC1 to protect cells from platinum-based anticancer agents. Youn CK; Kim MH; Cho HJ; Kim HB; Chang IY; Chung MH; You HJ Cancer Res; 2004 Jul; 64(14):4849-57. PubMed ID: 15256455 [TBL] [Abstract][Full Text] [Related]
20. A role for Akt in epidermal growth factor-stimulated cell cycle progression in cultured hepatocytes: generation of a hyperproliferative window after adenoviral expression of constitutively active Akt. Luo Y; Dixon CJ; Hall JF; White PJ; Boarder MR J Pharmacol Exp Ther; 2007 Jun; 321(3):884-91. PubMed ID: 17371807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]